Drug development

The development of biotechnologically produced drugs has made it possible to treat diseases at their cause, to do this more efficiently and with fewer side effects, or even to cure diseases. This is the focus of five biotechnology companies on Campus Berlin-Buch.

The spectrum of their drug development includes highly specific cancer antibodies (Glycotope GmbH), novel treatments targeting the cause of heart failure (Berlin Cures GmbH) or atrial fibrillation (OMEICOS Therapeutics GmbH), extremely effective antibiotics (MerLion Pharmaceuticals) and RNAi-based therapeutics for systemic cancers that can selectively regulate disease-related genes (Silence Therapeutics). Here, T-Knife, a spin-off from the Charité and the Max Delbrück Center, is developing one of the first T cell receptor gene therapies in Germany.

T-Knife GmbH

News innovation

Million euro support for MyoPax

MyoPax, a new spin-off of the Max Delbrück Center and Charité, receives a 1.3 million euros loan to jump-start its entrepreneurial activities. The start-up develops regenerative therapies for previous...

more ...

With patience and a green thumb

Viola Ehrig is the green-thumbed gardener who works hard to ensure it’s not only science and innovation that flourish at the Berlin-Buch campus, but trees and flowers as well. She and her colleague St...

more ...

Made in Berlin - Senator of Economics Schwarz visits Campus Buch

Berlin's Senator for Economics Stephan Schwarz joined State Secretary Michael Biel on August 17, 2022 to learn about the economic development of the Berlin Buch Science and Biotech Campus. During his ...

more ...

Events Campus

04.10.2022, 16:00
Auf der Suche nach der Gesundheit - Wie Forschung funktioniert

Vorlesungsreihe: Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch

more ...

06.10.2022, 09:00
Bioinformatik im Labor 4.0

Eine eintägige Einführung für Technische Angestellte und Laborant*innen in die aktuelle Bioinformatik und in das Next Generation Sequencing (NGS) mit praktischen Übungen zum Umgang mit Biodatenbanken.

more ...

07.11.2022, 09:00
Fachkraft für Molekularbiologie (TÜV)

Das 11-tägige Seminar vermittelt Grundlagen der wichtigsten Labormethoden der modernen Molekularbiologie und Einblicke in die klinische Forschung

more ...

Sponsoren der Website: